No Data
Kontafarma China Holdings Limited's (HKG:1312) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Konta China (01312) subsidiary company obtained temporary stay of winding-up petition pending Hong Kong legal proceedings from the Grand Court of Cayman Islands.
Jingu Finance News | konta china (01312) announced that the Cayman Islands court made a ruling last Thursday (3rd) on the application filed by its subsidiary, Fester Global, to revoke, reject, or suspend the ruling made in the Cayman Islands in 2024, pending the rulings of the 2019 Hong Kong legal proceedings and the 2021 Hong Kong legal proceedings. According to the Cayman ruling, the Cayman court has granted temporary case management suspension to the 2024 Cayman filing, pending the rulings of the Hong Kong proceedings. The group pointed out that the 2024 Cayman filing involves Active Gains Universal.
Cayman Court Grants Temporary Stay in Winding-Up Proceedings Against Kontafarma China Unit
Express News | Kontafarma China - Cayman Court Granted Temporary Case Management Stay of 2024 Cayman Petition Pending Determination of Hong Kong Proceedings
KONTA CHINA: 2024 INTERIM REPORT
Konta China [01312] is now trading at HKD0.027, a decrease of 12.90%.
As of 15:57, Konta China [01312] reported HKD 0.027, down by HKD 0.004 or 12.90% from yesterday's closing price of HKD 0.031. The trading volume is HKD 0.0002 million. The highest price today is HKD 0.027, and the lowest price is HKD 0.027. Based on yesterday's closing price, the 10-day average price is HKD 0.04, and the 50-day average price is HKD 0.03. The current P/E ratio is -6.92 times, and the 14-day strength index is reported at 57.89.
